Cracker Barrel Says It's Going Back to Its Old Logo After Backlash — Negative
CBRL WSJ — August 26, 2025The company's streamlined new look sparked a culture-war firestorm.
UNCY Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Unicycive Therapeutics, Inc. Class Action — Neutral
UNCY GlobeNewsWire — August 26, 2025SAN DIEGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Unicycive Therapeutics, Inc. (NASDAQ: UNCY) securities between March 29, 2024 and June 27, 2025. Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical needs in the U.S. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
SNAP INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Snap Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
SNAP GlobeNewsWire — August 26, 2025SAN DIEGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Snap Inc. (NYSE: SNAP) securities between April 29, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), have until October 20, 2025 to seek appointment as lead plaintiff of the Snap class action lawsuit. Captioned Abdul-Hameed v. Snap Inc., No. 25-cv-07844 (C.D. Cal.), the Snap class action lawsuit charges Snap as well as certain of Snap's top executives with violations of the Securities Exchange Act of 1934.
Summary Notice of Proposed Settlement of Derivative Matters — Neutral
OKTA GlobeNewsWire — August 26, 2025SAN FRANCISCO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Okta, Inc. has released the following notice: A Federal Court authorized this Notice. This is not a solicitation from a lawyer.
CHTR Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Charter Communications, Inc. Class Action — Neutral
CHTR GlobeNewsWire — August 26, 2025SAN DIEGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Charter Communications, Inc. (NASDAQ: CHTR) securities, purchased call options on Charter common stock, or sold put options on Charter common stock, between July 26, 2024 and July 24, 2025. Charter is a leading broadband, or high-speed Internet, connectivity company and cable operator.
UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals — Neutral
CPRX GlobeNewsWire — August 26, 2025As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035 As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035
Alphabet Lands $10B Meta Cloud Deal--Is A Siri-Gemini Deal Close? — Positive
GOOG GOOGL META Seeking Alpha — August 26, 2025Google Cloud secures $10B Meta deal, boosting growth and challenging the dominance of Amazon AWS and Microsoft Azure. This deal highlights the growing demand for advanced cloud infrastructure to support large-scale data analytics and AI workloads. Apple in talks with Google Gemini to power next-gen Siri, highlighting Gemini's strengths in speed, translation, and video.
Tariffs aren't enough to bring furniture manufacturing back to the U.S., Jim Cramer says — Neutral
RH W WSM CNBC — August 26, 2025CNBC's Jim Cramer told investors that he believes domestic furniture manufacturing is largely a thing of the past. "Some of these industries aren't probably going to come back," he said.
How a Superstore Strategy Fueled MINISO's 20% Stock Surge — Positive
MNSO MarketBeat — August 26, 2025Shares of MINISO Group NYSE: MNSO surged over 20% in the trading session following its second quarter 2025 earnings report, a dramatic move that signaled more than just a positive quarter. The market's enthusiastic response delivered a clear verdict on the company's evolving business strategy.
Cracker Barrel reverses course on new logo, brings back ‘Old Timer' after fan backlash: ‘We said we would listen' — Neutral
CBRL New York Post — August 26, 2025Cracker Barrel said Tuesday that after listening to its customers, it will scrap its new logo and keep the "Old Timer" in place.
Compared to Estimates, PVH (PVH) Q2 Earnings: A Look at Key Metrics — Positive
PVH Zacks Investment Research — August 26, 2025The headline numbers for PVH (PVH) give insight into how the company performed in the quarter ended July 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ooma (OOMA) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates — Positive
OOMA Zacks Investment Research — August 26, 2025Although the revenue and EPS for Ooma (OOMA) give a sense of how its business performed in the quarter ended July 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Kroger (KR) Stock Drops Despite Market Gains: Important Facts to Note — Neutral
KR Zacks Investment Research — August 26, 2025The latest trading day saw Kroger (KR) settling at $68.99, representing a -1.64% change from its previous close.
IonQ or Rigetti: Who Wins From Microsoft's Cloud Quantum Push? — Positive
IONQ RGTI Zacks Investment Research — August 26, 2025RGTI's chiplet tech, Azure integration, and solid financials put it ahead of IONQ as Microsoft fuels quantum's cloud future.
Too Much Hype! Should You Sell NVIDIA Stock Ahead of Q2 Earnings? — Negative
NVDA Zacks Investment Research — August 26, 2025NVIDIA's Q2 earnings spark debate as AI-driven growth, record GPU demand, and steep valuation fuel both optimism and caution.
SLQT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SelectQuote, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
SLQT GlobeNewsWire — August 26, 2025NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or “the Company”) (NYSE: SLQT) and certain of its officers.
TSLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tesla, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
TSLA GlobeNewsWire — August 26, 2025NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Tesla, Inc. (“Tesla” or “the Company”) (NASDAQ: TSLA) and certain of its officers.
BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025 — Neutral
BTAI GlobeNewsWire — August 26, 2025NEW HAVEN, Conn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it will host an investor call and live webcast at 8 a.m.
IRBT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRobot Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
IRBT GlobeNewsWire — August 26, 2025NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against iRobot Corporation (“iRobot” or “the Company”) (NASDAQ: IRBT) and certain of its officers.
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences — Neutral
ABOS GlobeNewsWire — August 26, 2025NEWTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer's disease, announced today that management will participate in the following upcoming investor conferences.